AIM-Bio Program Overview

AIM-Bio Program Overview

The AIM-Bio NC State and DTU Teams meet in Raleigh, NC

Funded by a US$27 million grant from the Novo Nordisk Foundation, the Accelerated Innovation in Manufacturing Biologics (AIM-Bio) project brings together two leading academic institutions, NC State University and the Technical University of Denmark. With complementary areas of experience and expertise, these two universities are creating an international collaborative enterprise engaged in education, lifelong learning, and process research and development in biomanufacturing science and technology. To address the future needs of the biopharmaceutical industry, BTEC, several departments at NC State, and the Technical University of Denmark (DTU) are carrying out this five-year project – from 2020 through 2025 to establish a world-class program in bioprocess research and development and workforce training that focuses on products and technologies critical to the future of biopharmaceutical manufacturing.

Learn about the key features of the AIM-Bio program:

9 new research projects that focus on technologies of critical importance to biopharmaceutical manufacturing.

8 new professional development courses which address topics particularly relevant to the future of biopharmaceutical manufacturing.

An international collaboration and exchange program providing for the exchange of investigators, technical staff, graduate students and postdocs between the U.S. and Denmark.

Establishment of an international Biopharma Leaders’ Network of experts and an annual Biopharmaceutical Manufacturing Symposium to foster development of new knowledge.